[1] Wang M, Moran AE, Liu J, et al.Cost-Effectiveness of Optimal Use of Acute Myocardial Infarction Treatments and Impact on Coronary Heart Disease Mortality in China[J]. Circulation: Cardiovascular Quality and Outcomes, 2014, 7(1): 78-85. [2] Weber, Karl T.Aldosterone in congestive heart failure[J]. New England Journal of Medicine, 2001, 10: 1056. [3] 王华,梁延春. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789. [4] ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test[J]. Am J Respir Crit Care Med, 2002, 116(1): 111-117. [5] Luo Y, Chen Q.Efficacy of aliskiren supplementation for heart failure: Ameta-analysis of randomized controlled trials[J]. Herz, 2019, 4(5): 398-404. [6] Bharathi U, Peter HB, Timothy MM, et al.The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial[J]. American Heart Journal, 2018, 201: 164-167. [7] Kristensen SL, Mogensen UM, Tarnesby G, et al.Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial[J]. European Journal of Heart Failure, 2018, 20(1): 136-147. [8] Vaduganathan M, Cheema B, Cleveland E, et al.Plasma renin activity, response to aliskiren,and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial[J]. European Journal of Heart Failure, 2018, 20(4): 677-686. [9] Gheorghiade M, Böhm M, Greene SJ, et al.For the ASTRONAUT Investigators and Coordinators, Effect of Aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure[J]. JAMA, 2013, 309: 1125-1135. [10] Byung-Hee Hwang, Sungmin Lim, Eun Ho Choo, et al.Long-term residual risk according to optimal medical treatment in acute myocardial infarction treated with percutaneous coronary[J]. Journal of the American College of Cardiology, 2015, 66(15): B95. |